secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2025-02-11T23:59:59+00:00
Accession:  0001356576-25-000006
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus schedules Q4 and full year 2024 earnings release and call for Feb 25, 2025
--------------------------------------------------------------------------------

- Earnings release expected after market close on Tuesday, February 25, 2025.
- Conference call at 4:30 pm ET hosted by CEO Jack Khattar and CFO Tim Dec.
- Live webcast accessible on Supernus Investor Relations website; replay for 60 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657625000006/0001356576-25-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657625000006/supn-20250211.htm
  HTML page:      https://secwatch.observer/filing/0001356576-25-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer